AAPL283.78+8.63 (+3.14%) ▲|ABBV253.35+10.21 (+4.20%) ▲|ABT94.12+0.88 (+0.94%) ▲|ACN128.98+3.16 (+2.51%) ▲|ADBE202.73+9.32 (+4.82%) ▲|AMAT626.84-41.16 (-6.16%) ▼|AMD521.58-10.99 (-2.06%) ▼|AMGN358.33+5.51 (+1.56%) ▲|AMT175.59+6.87 (+4.07%) ▲|AMZN232.69+5.68 (+2.50%) ▲|AVGO365.02-13.89 (-3.67%) ▼|AXP340.36-2.10 (-0.61%) ▼|BA217.25-0.87 (-0.40%) ▼|BAC57.88-0.31 (-0.53%) ▼|BKNG181.46+4.41 (+2.49%) ▲|BLK964.71-7.21 (-0.74%) ▼|BMY57.52+2.13 (+3.85%) ▲|BNY143.56-1.87 (-1.29%) ▼|BRK-B498.66+10.85 (+2.22%) ▲|C141.76-3.22 (-2.22%) ▼|CAT997.47-59.54 (-5.63%) ▼|CL92.07+1.01 (+1.11%) ▲|CMCSA23.17+0.48 (+2.12%) ▲|COF204.00-0.90 (-0.44%) ▼|COP105.96-0.45 (-0.42%) ▼|COST952.54+10.30 (+1.09%) ▲|CRM158.37+8.18 (+5.45%) ▲|CSCO113.77-5.20 (-4.37%) ▼|CVS104.34-0.32 (-0.31%) ▼|CVX171.06-1.18 (-0.69%) ▼|DE613.24-17.52 (-2.78%) ▼|DHR196.19+3.38 (+1.75%) ▲|DIS98.79+0.74 (+0.75%) ▲|DUK128.40+1.29 (+1.01%) ▲|EMR143.49-1.85 (-1.27%) ▼|FDX318.53-10.91 (-3.31%) ▼|GD346.71+2.01 (+0.58%) ▲|GE369.00-2.36 (-0.64%) ▼|GEV1,045.17-40.30 (-3.71%) ▼|GILD127.88+4.04 (+3.26%) ▲|GM78.10-0.43 (-0.55%) ▼|GOOG334.69-7.50 (-2.19%) ▼|GOOGL337.39-6.32 (-1.84%) ▼|GS1,019.61-45.48 (-4.27%) ▼|HD348.86+3.86 (+1.12%) ▲|HON232.21+0.97 (+0.42%) ▲|IBM271.63+13.36 (+5.17%) ▲|INTC128.32-4.55 (-3.42%) ▼|INTU267.72+12.65 (+4.96%) ▲|ISRG404.70+5.01 (+1.25%) ▲|JNJ254.66+9.78 (+3.99%) ▲|JPM329.05-6.07 (-1.81%) ▼|KO82.63+2.21 (+2.75%) ▲|LIN519.62-2.66 (-0.51%) ▼|LLY1,208.12+80.43 (+7.13%) ▲|LMT507.40+2.38 (+0.47%) ▲|LOW222.48+0.55 (+0.25%) ▲|LRCX379.09-22.73 (-5.66%) ▼|MA499.02+10.10 (+2.07%) ▲|MCD269.76+5.22 (+1.97%) ▲|MDLZ60.79-0.41 (-0.67%) ▼|MDT80.98+1.18 (+1.48%) ▲|META550.25+7.38 (+1.36%) ▲|MMM164.01-3.96 (-2.36%) ▼|MO73.79+0.58 (+0.79%) ▲|MRK128.66+3.21 (+2.56%) ▲|MS212.03-9.01 (-4.08%) ▼|MSFT372.97+20.14 (+5.71%) ▲|MU1,132.33-81.23 (-6.69%) ▼|NEE88.56+0.86 (+0.98%) ▲|NFLX73.81+2.91 (+4.10%) ▲|NKE40.75-0.15 (-0.37%) ▼|NOW98.34+8.82 (+9.85%) ▲|NVDA192.53-3.21 (-1.64%) ▼|ORCL148.53-3.93 (-2.58%) ▼|PEP141.39+1.87 (+1.34%) ▲|PFE24.29+0.62 (+2.62%) ▲|PG149.02+0.52 (+0.35%) ▲|PLTR112.93+5.66 (+5.28%) ▲|PM180.77+1.84 (+1.03%) ▲|QCOM189.39-15.51 (-7.57%) ▼|RTX187.99+1.40 (+0.75%) ▲|SBUX104.60+1.44 (+1.40%) ▲|SCHW90.67+1.23 (+1.38%) ▲|SO97.16+1.25 (+1.30%) ▲|SPG226.89+1.40 (+0.62%) ▲|T22.72+0.30 (+1.34%) ▲|TMO513.03+7.28 (+1.44%) ▲|TMUS182.68+1.11 (+0.61%) ▲|TSLA379.71+4.59 (+1.22%) ▲|TXN285.43-26.39 (-8.46%) ▼|UBER76.20+3.95 (+5.47%) ▲|UNH427.89+12.36 (+2.97%) ▲|UNP268.35+0.62 (+0.23%) ▲|UPS108.14-1.17 (-1.07%) ▼|USB60.91-0.30 (-0.49%) ▼|V336.23+5.71 (+1.73%) ▲|VZ46.54+0.47 (+1.02%) ▲|WFC83.86-0.88 (-1.04%) ▼|WMT115.69-0.09 (-0.08%) ▼|XOM136.54-1.01 (-0.73%) ▼|AAPL283.78+8.63 (+3.14%) ▲|ABBV253.35+10.21 (+4.20%) ▲|ABT94.12+0.88 (+0.94%) ▲|ACN128.98+3.16 (+2.51%) ▲|ADBE202.73+9.32 (+4.82%) ▲|AMAT626.84-41.16 (-6.16%) ▼|AMD521.58-10.99 (-2.06%) ▼|AMGN358.33+5.51 (+1.56%) ▲|AMT175.59+6.87 (+4.07%) ▲|AMZN232.69+5.68 (+2.50%) ▲|AVGO365.02-13.89 (-3.67%) ▼|AXP340.36-2.10 (-0.61%) ▼|BA217.25-0.87 (-0.40%) ▼|BAC57.88-0.31 (-0.53%) ▼|BKNG181.46+4.41 (+2.49%) ▲|BLK964.71-7.21 (-0.74%) ▼|BMY57.52+2.13 (+3.85%) ▲|BNY143.56-1.87 (-1.29%) ▼|BRK-B498.66+10.85 (+2.22%) ▲|C141.76-3.22 (-2.22%) ▼|CAT997.47-59.54 (-5.63%) ▼|CL92.07+1.01 (+1.11%) ▲|CMCSA23.17+0.48 (+2.12%) ▲|COF204.00-0.90 (-0.44%) ▼|COP105.96-0.45 (-0.42%) ▼|COST952.54+10.30 (+1.09%) ▲|CRM158.37+8.18 (+5.45%) ▲|CSCO113.77-5.20 (-4.37%) ▼|CVS104.34-0.32 (-0.31%) ▼|CVX171.06-1.18 (-0.69%) ▼|DE613.24-17.52 (-2.78%) ▼|DHR196.19+3.38 (+1.75%) ▲|DIS98.79+0.74 (+0.75%) ▲|DUK128.40+1.29 (+1.01%) ▲|EMR143.49-1.85 (-1.27%) ▼|FDX318.53-10.91 (-3.31%) ▼|GD346.71+2.01 (+0.58%) ▲|GE369.00-2.36 (-0.64%) ▼|GEV1,045.17-40.30 (-3.71%) ▼|GILD127.88+4.04 (+3.26%) ▲|GM78.10-0.43 (-0.55%) ▼|GOOG334.69-7.50 (-2.19%) ▼|GOOGL337.39-6.32 (-1.84%) ▼|GS1,019.61-45.48 (-4.27%) ▼|HD348.86+3.86 (+1.12%) ▲|HON232.21+0.97 (+0.42%) ▲|IBM271.63+13.36 (+5.17%) ▲|INTC128.32-4.55 (-3.42%) ▼|INTU267.72+12.65 (+4.96%) ▲|ISRG404.70+5.01 (+1.25%) ▲|JNJ254.66+9.78 (+3.99%) ▲|JPM329.05-6.07 (-1.81%) ▼|KO82.63+2.21 (+2.75%) ▲|LIN519.62-2.66 (-0.51%) ▼|LLY1,208.12+80.43 (+7.13%) ▲|LMT507.40+2.38 (+0.47%) ▲|LOW222.48+0.55 (+0.25%) ▲|LRCX379.09-22.73 (-5.66%) ▼|MA499.02+10.10 (+2.07%) ▲|MCD269.76+5.22 (+1.97%) ▲|MDLZ60.79-0.41 (-0.67%) ▼|MDT80.98+1.18 (+1.48%) ▲|META550.25+7.38 (+1.36%) ▲|MMM164.01-3.96 (-2.36%) ▼|MO73.79+0.58 (+0.79%) ▲|MRK128.66+3.21 (+2.56%) ▲|MS212.03-9.01 (-4.08%) ▼|MSFT372.97+20.14 (+5.71%) ▲|MU1,132.33-81.23 (-6.69%) ▼|NEE88.56+0.86 (+0.98%) ▲|NFLX73.81+2.91 (+4.10%) ▲|NKE40.75-0.15 (-0.37%) ▼|NOW98.34+8.82 (+9.85%) ▲|NVDA192.53-3.21 (-1.64%) ▼|ORCL148.53-3.93 (-2.58%) ▼|PEP141.39+1.87 (+1.34%) ▲|PFE24.29+0.62 (+2.62%) ▲|PG149.02+0.52 (+0.35%) ▲|PLTR112.93+5.66 (+5.28%) ▲|PM180.77+1.84 (+1.03%) ▲|QCOM189.39-15.51 (-7.57%) ▼|RTX187.99+1.40 (+0.75%) ▲|SBUX104.60+1.44 (+1.40%) ▲|SCHW90.67+1.23 (+1.38%) ▲|SO97.16+1.25 (+1.30%) ▲|SPG226.89+1.40 (+0.62%) ▲|T22.72+0.30 (+1.34%) ▲|TMO513.03+7.28 (+1.44%) ▲|TMUS182.68+1.11 (+0.61%) ▲|TSLA379.71+4.59 (+1.22%) ▲|TXN285.43-26.39 (-8.46%) ▼|UBER76.20+3.95 (+5.47%) ▲|UNH427.89+12.36 (+2.97%) ▲|UNP268.35+0.62 (+0.23%) ▲|UPS108.14-1.17 (-1.07%) ▼|USB60.91-0.30 (-0.49%) ▼|V336.23+5.71 (+1.73%) ▲|VZ46.54+0.47 (+1.02%) ▲|WFC83.86-0.88 (-1.04%) ▼|WMT115.69-0.09 (-0.08%) ▼|XOM136.54-1.01 (-0.73%) ▼|
22.2 C
New York
Saturday, June 27, 2026

Tag: compensation

newssourceFORcompanyinformationcontent1releasesmarket

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VSTS

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline.

Shareholders of Hims & Hers Health, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.

McPhy Energy : John Cockerill Hydrogen appointed as the buyer of the majority of McPhy’s activities, including the Belfort Gigafactory – Judicial reorganization proceedings...

Foussemagne (France), July 8, 2025 – 7.30 pm CEST

DMRC DEADLINE TODAY: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Digimarc Corporation Investors with Losses in Excess of $100K to Secure Counsel Before...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline.

La Rosa Realty LLC Enters in a Strategic Agreement with The Agency Dominican Republic Participating in IBIS Romana Bayahibe Project as a Co-Broker and...

Celebration, FL, July 08, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced a strategic agreement between its wholly owned subsidiary, La Rosa Realty LLC (“La Rosa Realty”), and The Agency Dominican Republic (“TADR”), securing rights for its agents to act as co-brokers to market and sell units of the IBIS Romana Bayahibe (“IBIS”) project in Dominican Republic, and exclusive rights for any sales of IBIS in Puerto Rico.

Edf: EDF group governance changes

EDF group governance changes  

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Apple Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AAPL

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, both dates inclusive (the “Class Period”), of the important August 19, 2025 lead plaintiff deadline.

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DDD

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important August 12, 2025 lead plaintiff deadline.

Finlay Minerals Ltd. engages Investing News Network

VANCOUVER, BC, July 7, 2025 /CNW/ - Finlay Minerals Ltd. (TSXV: FYL) (OTCQB: FYMNF) ("Finlay" or the "Company") reports that it has engaged Dig Media Inc....

Franklin Electric Appoints Daniela Williams as Chief Human Resources Officer to Lead Talent and Culture Strategy

FORT WAYNE, Ind., July 07, 2025 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) announced that Daniela Williams will join its executive leadership team as Chief Human Resources Officer (CHRO), bringing a proven track record of driving growth for global organizations.

La Rosa Holdings Corp. Launches New Transaction Management Module, Intended to Deliver Significant Cost Savings and Operational Efficiencies

Celebration, FL, July 07, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0, a major enhancement to the Company’s proprietary agent platform. The new version, which went live on July 1, 2025, features a fully integrated Transaction Management module that is intended to deliver significant cost savings to the Company by improving efficiency, reducing manual processes, and eliminating reliance on expensive third-party systems.

Make a Splash with Summer Savings at Natural Grocers®, July 10-12, 2025

Customers can enjoy sizzling deals of up to 36% off and a chance to win a Lake Tahoe getaway, plus a fun in-store scavenger...

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients...

-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population --

-- Bezuclastinib demonstrated a powerful effect on mast cell burden, with 87.4% of patients treated with bezuclastinib achieving at least 50% reduction in serum tryptase compared to 0% of patients treated with placebo --

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompensation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers